Breaking News

AstraZeneca Plans New R&D Center and Alexion Headquarters

Move brings together AstraZeneca and Alexion colleagues in a purpose-built facility in Kendall Square, Cambridge, MA life sciences hub.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AstraZeneca has unveiled plans to open a new site at the heart of the Cambridge, MA, life sciences and innovation hub. The new site will be a strategic R&D center for AstraZeneca, as well as Alexion’s new corporate headquarters. The site will bring together approximately 1,500 R&D, commercial and corporate colleagues into a single purpose-built space in Kendall Square, Cambridge, MA. The site, scheduled for completion in 2026, will be in close proximity to several major academic, p...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters